Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.94% | 88.65 | 1.3% | $803.98m | |
| AMGN | Amgen Inc. | -0.76% | 185.50 | 1.2% | $628.99m | |
| GILD | Gilead Sciences, Inc. | -2.14% | 65.55 | 0.9% | $482.29m | |
| BIIB | Biogen Inc. | -4.17% | 321.17 | 1.3% | $427.44m | |
| ILMN | Illumina, Inc. | -1.77% | 296.88 | 3.5% | $311.35m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.92% | 418.62 | 2.6% | $290.18m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.55% | 183.06 | 1.9% | $253.58m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.76% | 127.55 | 2.0% | $219.68m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.87% | 136.54 | 15.4% | $152.33m | |
| A | Agilent Technologies, Inc. | -0.83% | 77.91 | 1.6% | $150.84m | |
| EXAS | Exact Sciences Corporation | -0.42% | 83.28 | 25.3% | $132.28m | |
| INCY | Incyte Corporation | -0.49% | 83.33 | 2.5% | $111.93m | |
| ARRY | Array BioPharma Inc. | -1.99% | 22.71 | 8.2% | $108.01m | |
| EXEL | Exelixis, Inc. | -0.09% | 21.22 | 6.4% | $82.07m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.58% | 77.31 | 5.1% | $77.22m |
Company Profile
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.